[Answered] Munchausen's syndrome is coded to: a. F68.12. b. F68.10. c. F68.8. d. ...

This topic contains a solution. Click here to go to the answer

Author Question: Munchausen's syndrome is coded to: a. F68.12. b. F68.10. c. F68.8. d. ... (Read 26 times)

skymedlock

Hero Member
Posts: 561

on: Jun 27, 2018

Munchausen's syndrome is coded to:

a. F68.12.
b. F68.10.
c. F68.8.
d. F68.13.

Question 2

Childhood separation anxiety:

a. F93.9.
b. F93.8.
c. F93.0.
d. None of the above.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

kmb352

Sr. Member
Posts: 319

Reply #1 on: Jun 27, 2018

Answer to Question 1

Answer: b

Answer to Question 2

Answer: c

skymedlock

Member
Posts: 561

Reply 2 on: Jun 27, 2018

Thanks for the timely response, appreciate it

dawsa925

Member
Posts: 326

Reply 3 on: Yesterday

Gracias!

« previous next »

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

People who have myopia, or nearsightedness, are not able to see objects at a distance but only up close. It occurs when the cornea is either curved too steeply, the eye is too long, or both. This condition is progressive and worsens with time. More than 100 million people in the United States are nearsighted, but only 20% of those are born with the condition. Diet, eye exercise, drug therapy, and corrective lenses can all help manage nearsightedness.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

In the United States, an estimated 50 million unnecessary antibiotics are prescribed for viral respiratory infections.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.